TY - JOUR
T1 - Longitudinal predictors of continued tobacco use among patients diagnosed with cancer
AU - Schnoll, Robert A.
AU - James, Calvin
AU - Malstrom, Michael
AU - Rothman, Randi L.
AU - Wang, Hao
AU - Babb, James
AU - Miller, Suzanne M.
AU - Ridge, John A.
AU - Movsas, Benjamin
AU - Langer, Corey
AU - Unger, Michael
AU - Goldberg, Melvyn
N1 - Funding Information:
Support for this study was provided by National Institutes of Health Grants CA57708, CA06927, CA88610, CA95678, and CA76644.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003
Y1 - 2003
N2 - Even though continued smoking by cancer patients adversely affects survival and quality of life, about one third of patients who smoked prior to their diagnosis continue to smoke after their diagnosis. The implementation of smoking cessation treatments for cancer patients has been slowed by the lack of data on correlates of tobacco use in this population. Thus, this longitudinal study assessed demographic, medical, addiction, and psychological predictors of tobacco use among 74 head, neck, and lung cancer patients. Multivariable binary logistic regression analyses, with outcome categorized as smoker or nonsmoker, indicated that the likelihood that patients would be a smoker was associated with lower levels of perceived risk and a higher level of quitting cons. Multivariable nominal logistic regression, with outcome classified as continuous smoker, continuous quitter, relapser, or follow-up quitter, indicated that: (a) patients categorized as continuous smokers reported significantly lower quitting self-efficacy than follow-up quitters and continuous quitters, (b) relapsers reported a significantly lower level of quitting self-efficacy than either follow-up quitters or continuous quitters, and(c)(c) continuous smokers exhibited a significantly lower level of risk perceptions than continuous abstainers. These findings can be useful for the development and evaluation of treatments to promote smoking cessation among cancer patients.
AB - Even though continued smoking by cancer patients adversely affects survival and quality of life, about one third of patients who smoked prior to their diagnosis continue to smoke after their diagnosis. The implementation of smoking cessation treatments for cancer patients has been slowed by the lack of data on correlates of tobacco use in this population. Thus, this longitudinal study assessed demographic, medical, addiction, and psychological predictors of tobacco use among 74 head, neck, and lung cancer patients. Multivariable binary logistic regression analyses, with outcome categorized as smoker or nonsmoker, indicated that the likelihood that patients would be a smoker was associated with lower levels of perceived risk and a higher level of quitting cons. Multivariable nominal logistic regression, with outcome classified as continuous smoker, continuous quitter, relapser, or follow-up quitter, indicated that: (a) patients categorized as continuous smokers reported significantly lower quitting self-efficacy than follow-up quitters and continuous quitters, (b) relapsers reported a significantly lower level of quitting self-efficacy than either follow-up quitters or continuous quitters, and(c)(c) continuous smokers exhibited a significantly lower level of risk perceptions than continuous abstainers. These findings can be useful for the development and evaluation of treatments to promote smoking cessation among cancer patients.
UR - http://www.scopus.com/inward/record.url?scp=0038797782&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038797782&partnerID=8YFLogxK
U2 - 10.1207/S15324796ABM2503_07
DO - 10.1207/S15324796ABM2503_07
M3 - Article
C2 - 12763716
AN - SCOPUS:0038797782
SN - 0883-6612
VL - 25
SP - 214
EP - 221
JO - Annals of Behavioral Medicine
JF - Annals of Behavioral Medicine
IS - 3
ER -